DAX24.077 -0,6%Est505.718 -0,6%MSCI World4.343 -0,1%Top 10 Crypto11,48 +1,8%Nas23.111 +0,2%Bitcoin74.685 +1,6%Euro1,1748 ±-0,0%Öl58,87 -2,5%Gold4.302 -0,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 DroneShield A2DMAA NVIDIA 918422 Lufthansa 823212 Tesla A1CX3T TUI TUAG50 Bayer BAY001 Deutsche Telekom 555750 Siemens Energy ENER6Y RENK RENK73 BASF BASF11 Volkswagen (VW) vz. 766403 Mercedes-Benz Group (ex Daimler) 710000 Novo Nordisk A3EU6F Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Arbeitsmarktdaten durchwachsen: DAX beendet Handel im Minus -- US-Börsen tiefer -- DroneShield erhält Großauftrag aus Europa -- Ölpreise, Rüstungsaktien, Bayer, ServiceNow, Palantir im Fokus
Top News
NASDAQ plant Handelsrevolution: Aktienhandel künftig nahezu rund um die Uhr möglich NASDAQ plant Handelsrevolution: Aktienhandel künftig nahezu rund um die Uhr möglich
Allianz Global Investors Ausblick 2026: Handelskriege, KI und Politik - die Treiber des kommenden Jahres Allianz Global Investors Ausblick 2026: Handelskriege, KI und Politik - die Treiber des kommenden Jahres
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Dynavax Technologies Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
9,24 EUR +0,01 EUR +0,11 %
BMN
10,79 USD -0,07 USD -0,60 %
BTT
Dynavax Technologies jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.1,08 Mrd. EUR

KGV62,35Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA12EV9

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS2681582019

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDVAX

Dynavax Technologies Aktien News

DatumMeistgelesen
PR NewswireDynavax to Participate at the 8th Annual Evercore Healthcare Conference
PR NewswireDynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
PR NewswireDynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
Wer­bungDynavax Technologies-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireDynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
PR NewswireDynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
PR NewswireDynavax to Participate in the 2025 Wells Fargo Healthcare Conference
PR NewswireDynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile
PR NewswireDynavax Reports Second Quarter 2025 Financial Results
PR NewswireDynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
PR NewswireDynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
PR NewswireDynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
PR NewswireDynavax Comments on Glass Lewis Recommendation
PR NewswireDynavax to Present at William Blair's 45th Annual Growth Stock Conference
PR NewswireLeading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees
PR NewswireDynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value
PR Newswire/C O R R E C T I O N -- Dynavax Technologies/
PR NewswireDynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum
PR NewswireDynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs
PR NewswireDynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits
PR NewswireDynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
PR NewswireDynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
PR NewswireDynavax Files Definitive Proxy Statement and Sends Letter to Stockholders
PR NewswireDynavax Files Preliminary Proxy Statement
PR NewswireDynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
PR NewswireDynavax to Participate in Upcoming Investor Conferences
PR NewswireDynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance
PR NewswireDynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy
PR NewswireDynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025
PR NewswireDynavax Advances Board Refreshment Program
PR NewswireDynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
PR NewswireDynavax to Present at the 7th Annual Evercore HealthCONx Conference
PR NewswireDynavax Announces $100 Million Accelerated Share Repurchase Program
PR NewswireDynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
PR NewswireDynavax Announces $200 Million Share Repurchase Program
PR NewswireDynavax Adopts Limited-Duration Stockholder Rights Plan
PR NewswireDynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
PR NewswireDynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates
PR NewswireDynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024
PR NewswireDynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program
PR NewswireDynavax to Present at Upcoming Investor Conferences

Dynavax Technologies News

Dynavax Technologies News: auf dieser Seite finden Sie alle Dynavax Technologies News und Nachrichten zur Dynavax Technologies Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Dynavax Technologies News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Dynavax Technologies News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.